BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 18937733)

  • 1. How much residual plasma may cause TRALI?
    Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
    Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007).
    Keller-Stanislawski B; Reil A; Günay S; Funk MB
    Vox Sang; 2010 Jan; 98(1):70-7. PubMed ID: 19671122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion related acute lung injury (TRALI) caused by red blood cell transfusion involving residual plasma anti-HLA antibodies: a report on two cases and general considerations.
    Odent-Malaure H; Quainon F; Ruyer-Dumontier P; Ducroz S; Verdier P; Voitellier E; Raynal MF; Fromont P; Muller JY; Rebibo D; Absi L; Garraud O
    Clin Dev Immunol; 2005 Dec; 12(4):243-8. PubMed ID: 16584109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
    Reil A; Keller-Stanislawski B; Günay S; Bux J
    Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-related acute lung injury reports in the Netherlands: an observational study.
    van Stein D; Beckers EA; Sintnicolaas K; Porcelijn L; Danovic F; Wollersheim JA; Brand A; van Rhenen DJ
    Transfusion; 2010 Jan; 50(1):213-20. PubMed ID: 19694998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion-related acute lung injury (TRALI): a case report and literature review.
    Donelan KJ; Anderson KA
    S D Med; 2011 Mar; 64(3):85-8. PubMed ID: 21473518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience.
    Sachs UJ; Link E; Hofmann C; Wasel W; Bein G
    Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross.
    Eder AF; Herron R; Strupp A; Dy B; Notari EP; Chambers LA; Dodd RY; Benjamin RJ
    Transfusion; 2007 Apr; 47(4):599-607. PubMed ID: 17381617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
    Curtis BR; McFarland JG
    Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR antibodies in transfusion-related acute lung injury (TRALI): a case report.
    Muro M; Rivera J; Botella C; Campillo JA; Ferrer F; Alvarez-López MR
    Transfus Apher Sci; 2008 Jun; 38(3):209-12. PubMed ID: 18462996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of a strategy to prevent TRALI in a regional blood centre.
    Insunza A; Romon I; Gonzalez-Ponte ML; Hoyos A; Pastor JM; Iriondo A; Hermosa V
    Transfus Med; 2004 Apr; 14(2):157-64. PubMed ID: 15113380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion-related acute lung injury prevention measures and their impact at Canadian Blood Services.
    Lin Y; Saw CL; Hannach B; Goldman M
    Transfusion; 2012 Mar; 52(3):567-74. PubMed ID: 21895676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury.
    Hashimoto S; Nakajima F; Kamada H; Kawamura K; Satake M; Tadokoro K; Okazaki H
    Transfusion; 2010 Dec; 50(12):2582-91. PubMed ID: 20667042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-related acute lung injury and leucocyte-reacting antibodies.
    Zupanska B; Uhrynowska M; Michur H; Maslanka K; Zajko M
    Vox Sang; 2007 Jul; 93(1):70-7. PubMed ID: 17547568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-mediated (immune) transfusion-related acute lung injury.
    Bux J
    Vox Sang; 2011 Jan; 100(1):122-8. PubMed ID: 21175662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States.
    Kleinman S; Grossman B; Kopko P
    Transfusion; 2010 Jun; 50(6):1312-21. PubMed ID: 20456690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors.
    Saw CL; Hannach B; Petrazsko T; Nickerson P
    Transfusion; 2013 Mar; 53(3):518-25. PubMed ID: 22738429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.
    Powers A; Stowell CP; Dzik WH; Saidman SL; Lee H; Makar RS
    Transfusion; 2008 Dec; 48(12):2549-58. PubMed ID: 18717778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury.
    Toy P; Hollis-Perry KM; Jun J; Nakagawa M
    Transfusion; 2004 Dec; 44(12):1683-8. PubMed ID: 15584980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion-related acute lung injury: current concepts for the clinician.
    Triulzi DJ
    Anesth Analg; 2009 Mar; 108(3):770-6. PubMed ID: 19224781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.